Literature DB >> 1379601

Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site.

S J Theroux1, D A Latour, K Stanley, D L Raden, R J Davis.   

Abstract

It has been proposed that the acute desensitization of epidermal growth factor receptor (EGF-R) function can be accounted for, in part, by the effect of EGF to increase phosphorylation of the receptor at Ser1046/7 (Countaway, J.L., Nairn, A.C., and Davis, R.J. (1992) J. Biol. Chem. 267, 1129-1140). Here, we show that the mutational removal of this phosphorylation site causes an activation of EGF-R function and a potentiation of signal transduction. The mechanism of potentiation results from 1) defective down-regulation of the EGF-R when cells are incubated with high concentrations of EGF; and 2) increased EGF-stimulated tyrosine phosphorylation. The increased EGF-stimulated phosphorylation is associated with an alteration of the apparent specificity of tyrosine phosphorylation and is independent of the down-regulation defect. Together, these data strongly support the hypothesis that Ser1046/7 is a biologically significant site of regulatory phosphorylation of the EGF-R.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379601

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.

Authors:  Tyler Lahusen; Mark Fereshteh; Annabell Oh; Anton Wellstein; Anna T Riegel
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.

Authors:  Seiji Adachi; Ichiro Yasuda; Masanori Nakashima; Takahiro Yamauchi; Junji Kawaguchi; Masahito Shimizu; Masahiko Itani; Momoko Nakamura; Yumi Nishii; Takashi Yoshioka; Yoshinobu Hirose; Yukio Okano; Hisataka Moriwaki; Osamu Kozawa
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

3.  Induction of renal adenocarcinoma by a nonmutated erbB oncogene.

Authors:  C A Taglienti-Sian; B Banner; R J Davis; H L Robinson
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

4.  Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.

Authors:  Tomohiro Tanaka; Yue Zhou; Tatsuhiko Ozawa; Ryuya Okizono; Ayako Banba; Tomohiro Yamamura; Eiji Oga; Atsushi Muraguchi; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2017-12-18       Impact factor: 5.157

5.  Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor.

Authors:  Hongbing Li; Antonio Villalobo
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

6.  Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer.

Authors:  X Ouyang; T Gulliford; H Zhang; G Smith; G Huang; R J Epstein
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

7.  The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

Authors:  Hongbing Li; Juan Sánchez-Torres; Alan Del Carpio; Valentina Salas; Antonio Villalobo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

8.  Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF.

Authors:  S M Schuh; E P Newberry; M A Dalton; L J Pike
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

9.  Regulation of protein tyrosine kinase signaling by substrate degradation during brain development.

Authors:  Lionel Arnaud; Bryan A Ballif; Jonathan A Cooper
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells.

Authors:  Junji Kawaguchi; Seiji Adachi; Ichiro Yasuda; Takahiro Yamauchi; Masanori Nakashima; Tomohiko Ohno; Masahito Shimizu; Takashi Yoshioka; Masahiko Itani; Osamu Kozawa; Hisataka Moriwaki
Journal:  Mol Cancer       Date:  2012-07-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.